Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Zymergen Inc.
  6. Summary
    ZY   US98985X1000

ZYMERGEN INC.

(ZY)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/19/2021 07/20/2021 07/21/2021 07/22/2021 07/23/2021 Date
38.57(c) 39.64(c) 38.07(c) 38.81(c) 39.87 Last
470 214 331 711 285 191 326 049 228 150 Volume
+7.29% +2.77% -3.96% +1.94% +2.73% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 28,8 M - -
Net income 2021 -331 M - -
Net cash position 2021 328 M - -
P/E ratio 2021 -10,4x
Yield 2021 -
Sales 2022 136 M - -
Net income 2022 -261 M - -
Net cash position 2022 96,1 M - -
P/E ratio 2022 -17,2x
Yield 2022 -
Capitalization 3 894 M 3 894 M -
EV / Sales 2021 124x
EV / Sales 2022 28,0x
Nbr of Employees 758
Free-Float 90,9%
More Financials
Company
Zymergen Inc. integrates computational and manufacturing technologies to design, engineer, and optimize microbes for industrial applications. The Company has developed a platform that treats the genome as a search space, utilizing machine learning algorithms and advanced automation to identify genetic changes. The Company's biofacturing platform, is a fusion of biology, chemistry and technology, is built on a stack... 
Sector
Personal Products
Calendar
-
More about the company
All news about ZYMERGEN INC.
07/06ZYMERGEN : HSBC Starts Zymergen at Hold With $42 Price Target
MT
06/29ZYMERGEN : William Blair Initiates Coverage on Zymergen With Outperform Rating
MT
06/21ZYMERGEN INC.(NASDAQGS : ZY) added to S&P TMI Index
CI
06/07Zymergen to Present at Goldman Sachs Annual Global Healthcare Conference
GL
05/28ZYMERGEN : Acquires Lodo Therapeutics for Undisclosed Sum, Says Sponsor ALSP
MT
05/27ZYMERGEN : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
05/24ZYMERGEN : Preliminary Q1 Loss Widens on Higher Revenue
MT
05/24ZYMERGEN : Reports Preliminary First Quarter 2021 Financial Results (Form 8-K)
PU
05/24Zymergen Reports Preliminary First Quarter 2021 Financial Results
GL
05/24Zymergen Inc. Announces Unaudited Earnings Results for the First Quarter Ende..
CI
05/24GLOBAL MARKETS LIVE : Boeing, Airbus, Moderna, Virgin Galactic, Siegfried...
05/21Zymergen to Present at UBS Global Healthcare Virtual Conference
GL
05/17ZYMERGEN : BofA Securities Initiates Zymergen at Buy Rating With $43 Price Targe..
MT
05/17ZYMERGEN : Cowen Initiates Zymergen at Outperform Rating
MT
05/17ZYMERGEN : JPMorgan Starts Zymergen at Overweight With $40 Price Target
MT
More news
News in other languages on ZYMERGEN INC.
05/24STOCK MARKET PARIS : La recherche de catalyseurs haussiers patine
05/24EN DIRECT DES MARCHES : Airbus, EssilorLuxottica, Solutions 30, Tarkett, Boeing,..
More news
Analyst Recommendations on ZYMERGEN INC.
More recommendations
Chart ZYMERGEN INC.
Duration : Period :
Zymergen Inc. Technical Analysis Chart | ZY | US98985X1000 | MarketScreener
Technical analysis trends ZYMERGEN INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 38,81 $
Average target price 47,20 $
Spread / Average Target 21,6%
EPS Revisions
Managers and Directors
Joshua J. Hoffman Chief Executive Officer & Director
Enakshi Singh Chief Financial Officer
Jay T. Flatley Chairman
Zachariah Serber Director & Chief Science Officer
Jed Dean Vice President-Operations & Engineering
Sector and Competitors
1st jan.Capi. (M$)
ZYMERGEN INC.0.00%4 128
PROCTER & GAMBLE COMPANY-0.96%330 316
UNILEVER PLC-7.78%154 411
THE ESTÉE LAUDER COMPANIES INC.22.69%114 536
HINDUSTAN UNILEVER LIMITED-1.43%77 609
COLGATE-PALMOLIVE COMPANY-4.29%68 913